Risk factors for immune-related adverse events: what have we learned and what lies ahead?

• Main Authors: Xiaoyan Liu (Author), Yuequan Shi (Author), Dongming Zhang (Author), Qing Zhou (Author), Jia Liu (Author), Minjiang Chen (Author), Yan Xu (Author), Jing Zhao (Author), Wei Zhong (Author), Mengzhao Wang (Author)
• Format: Book
• Published: BMC, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Immune checkpoint inhibitors (ICIs) have heralded the advent of a new era in oncology by holding the promise of prolonged survival in severe and otherwise treatment-refractory advanced cancers. However, the remarkable antitumor efficacy of these agents is overshadowed by their potential for...